“To maximize the opportunity, however, RVNC will need a partner to co-market Daxxify for therapeutic indications.”
We are essentially three weeks from an FDA ruling on “potential” approval for CD. It strikes me odd there has been no announcement on a partner for sales into this medical/therapeutic indication. I sure hope the Executives are laser focused on launching immediately for CD pending approval.
News 
Market Data 
Discover 
AI
